What is the Org number of Ocular Oncology Sweden AB?

Ocular Oncology Sweden AB is registered with Bolagsverket / SCB under Org 5593247918.

What is the revenue of Ocular Oncology Sweden AB?

Ocular Oncology Sweden AB reported revenue of SEK 176K in 2025.

Who is the chairman of Ocular Oncology Sweden AB?

Birgitta Charlotta All Eriksson chairs the board of Ocular Oncology Sweden AB, in role since 2022.

Riskpilot← Back to search

Sign inGet full access

Ocular Oncology Sweden AB

ABActive

Org 5593247918Medical specialists activities · NACE 8622Est. 20210 employees

Overview Financials People & ownership Related companies

Financials

Revenue

SEK millions

EBITDA

SEK millions

Income statement

SEK thousands

Item	2021	2022	2023	2024	2025
Revenue	4 876	3 762	196	199	176
Staff expenses	—	—	−166	−186	−237
EBITDA	4 144	3 004	−63	−54	−132
Depreciation & amort.	−0	—	—	—	—
EBIT	4 144	3 004	−63	−54	−132
Net financials	—	—	13	13	234
Profit before tax	3 144	2 254	0	−42	141
Tax	−652	−467	−8	−5	−1
Net profit	2 492	1 787	−8	−47	142

Balance sheet

SEK thousands

Item	2021	2022	2023	2024	2025
Total assets	5 755	7 190	6 209	5 606	5 507
Equity	2 517	4 304	3 903	3 653	3 585
Long-term debt	0	—	—	—	—
Short-term debt	2 238	1 137	605	253	260
Total debt	2 238	1 137	605	253	260

Financial ratios

5-year trend

EBITDA margin

-74.7%

This company

15.8%

Market median

-573% vs market

20212025

Equity ratio

65.1%

This company

38.2%

Market median

+70% vs market

20212025

Return on equity

4.0%

This company

18.4%

Market median

-78% vs market

20212025

Net profit margin

80.5%

This company

8.1%

Market median

+894% vs market

20212025

Asset turnover

0.03×

This company

1.12×

Market median

-97% vs market

20212025

Debt / equity

0.54×

This company

0.62×

Market median

+13% vs market

20212025

Annual reports & filings

Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-06-01 – 2021-12-31

Ocular Oncology Sweden AB

Financials

Revenue

EBITDA

Income statement

Balance sheet

Financial ratios

Annual reports & filings

More on Ocular Oncology Sweden AB

Financials

Revenue

EBITDA

Income statement

Balance sheet

Financial ratios

Annual reports & filings

More on Ocular Oncology Sweden AB